Sort
50,496 grants matching “lung cancer”
Addressing Urban Rural Disparities in Cancer: The Case for Registry Expansion
$475,193Cathy J. Bradley · University Of Colorado Denver · R01 · FY2020 · CA
Interaction of histamine-releasing factor with immunoglobulins in asthma
$475,181Toshiaki Kawakami · La Jolla Institute For Immunology · R01 · FY2017 · HL
Multi-institutional validation of a multi-modal machine learning algorithm to predict and reduce acute care during cancer therapy
$475,152Julian Clint Hong · University Of California, San Francisco · R01 · FY2025 · CA
Integrated analyses of cancers harboring STK11 vs. TSC1/2 vs. PTEN Loss
$475,087David J. Kwiatkowski · Brigham And Women'S Hospital · P01 · FY2015 · CA
EFFECT OF TOBACCO AT THE STATE LEVEL
$475,056University Of California San Francisco · R01 · FY2005 · CA
Epigenetic Stress and Chromate Carcinogenesis
$475,047Max Costa · New York University School Of Medicine · R01 · FY2020 · ES
Early Stage Lung Cancer
$475,019Kemp Kernstine · Beckman Research Institute/City Of Hope · P01 · FY2013 · CA
Spatially-resolved proteome mapping of senescent cells and their tissue microenvironment at single-cell resolution
$475,000Ljiljana Pasa-Tolic · Battelle Pacific Northwest Laboratories · UG3 · FY2022 · CA
Spatially-resolved proteome mapping of senescent cells and their tissue microenvironment at single-cell resolution
$474,999Ljiljana Pasa-Tolic · Battelle Pacific Northwest Laboratories · UG3 · FY2023 · CA
Clustered semi-competing risks analysis in quality of end-of-life care studies
$474,959Sebastien Haneuse · Harvard School Of Public Health · R01 · FY2014 · CA
Risk Factors for Sepsis in the Community
$474,942Henry E Wang · University Of Alabama At Birmingham · R01 · FY2015 · NR
PHARMACOLOGICAL TARGETING OF GALPHA SUBUNITS IN DISEASE
$474,941Kendall Jay Blumer · Washington University · R01 · FY2021 · GM
Prevalence of environmental and genetic risk factors for gastric cancer in a popu
$474,935Lovell Allan Jones · University Of Tx Md Anderson Can Ctr · P60 · FY2007 · MD
Genetic and epigenetic risk markers for lung cancer in former smokers
$474,931Sungshim Lani Park · University Of Minnesota · P01 · FY2025 · CA
Targeting SNP BRMS1v2 A273V/A273V to reduce metastases in lung adenocarcinoma
$474,928David R Jones · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
Targeting SNP BRMS1v2 A273V/A273V to reduce metastases in lung adenocarcinoma
$474,928David R Jones · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Metabolism of Carcinogenic Tobacco-Specific Nitrosamines
$474,878University Of Minnesota Twin Cities · R37 · FY2005 · CA
NanoOptogenetic immunotherapy for B cell lymphoma
$474,840Gang Han · Univ Of Massachusetts Med Sch Worcester · R01 · FY2019 · CA
Laser speckle flowgraphy as early indicator of microvasculopathy in radiation-induced vision loss
$474,836Isabella Maria Grumbach · University Of Iowa · R01 · FY2022 · EY
Laser speckle flowgraphy as early indicator of microvasculopathy in radiation-induced vision loss
$474,835Isabella Maria Grumbach · University Of Iowa · R01 · FY2021 · EY
Imaging Feedback to Guide Ultrasonic Tissue Fractionation for Cancer Therapy
$474,760Charles Alan Cain · University Of Michigan At Ann Arbor · R01 · FY2010 · CA
AZD9668 and Neutrophil Elastase Inhibition to Prevent Graft-versus-Host Disease
$474,721Nelson J. Chao · Duke University · UG3 · FY2018 · TR
Role of EGFR Ligands in Neoplasia
$474,694Robert J Coffey · Vanderbilt University · R01 · FY2013 · CA
Metabolism of Carcinogenic Tobacco-Specific Nitrosamines
$474,673Stephen S Hecht · University Of Minnesota · R37 · FY2007 · CA
Software for Meta-Analysis of Diagnostic Tests
$474,666Michael Borenstein · Biostatistical Programming Assoc, Inc. · R44 · FY2008 · AG